Evolent Health
EVH
EVH
232 hedge funds and large institutions have $2.76B invested in Evolent Health in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 86 increasing their positions, 85 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $3.35B → $2.76B (-$589M)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
31% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 49
Holders
232
Holding in Top 10
8
Calls
$11.6M
Puts
$6.4M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$43.8M | |
| 3 | +$41.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$25.9M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$20M | |
| 3 | -$18.1M | |
| 4 |
JP Morgan Chase
New York
|
-$13.7M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$13.2M |